(Q43777229)

English

Improved survival after one course of perioperative chemotherapy in early breast cancer patients. long-term results from the European Organization for Research and Treatment of Cancer (EORTC) Trial 10854.

scientific article published in November 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Improved survival after one course of perioperative chemotherapy in early breast cancer patients. long-term results from the European Organization for Research and Treatment of Cancer (EORTC) Trial 10854. (English)

1 reference

Europe PubMed Central

26 November 2017

1 reference

based on heuristic

inferred from title

author name string

van der Hage JA

1

1 reference

Europe PubMed Central

26 November 2017

van de Velde CJ

2

1 reference

Europe PubMed Central

26 November 2017

Julien JP

3

1 reference

Europe PubMed Central

26 November 2017

Floiras JL

4

1 reference

Europe PubMed Central

26 November 2017

Delozier T

5

1 reference

Europe PubMed Central

26 November 2017

Vandervelden C

6

1 reference

Europe PubMed Central

26 November 2017

Duchateau L

7

1 reference

Europe PubMed Central

26 November 2017

publication date

1 November 2001

1 reference

Europe PubMed Central

26 November 2017

European Journal of Cancer

1 reference

Europe PubMed Central

26 November 2017

37

1 reference

Europe PubMed Central

26 November 2017

2184-2193

1 reference

Europe PubMed Central

26 November 2017

17

1 reference

Europe PubMed Central

26 November 2017

Combination adjuvant chemotherapy for node-positive breast cancer. Inadequacy of a single perioperative cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900294-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900294-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized cooperative study of perioperative chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900294-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900294-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900294-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical adjuvant chemotherapy: results with one short course with cyclophosphamide after mastectomy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900294-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Perioperative adjuvant chemotherapy in breast cancer. The Scandinavian Adjuvant Chemotherapy Study 1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900294-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Is there a role for perioperative adjuvant cytotoxic therapy in the treatment of early breast cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900294-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900294-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of f

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900294-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomized multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900294-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900294-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900294-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(01)00294-5

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43777229&oldid=2103236572"